Parth Parmar: Practical Guidelines for Managing Venous Thromboembolism
Parth Parmar, Attending Physician at District hospital, Gandhidham, shared a post on LinkedIn:
“Venous Thromboembolism Guidelines Series | A Practical Clinical Apprroach
Venous thromboembolism (VTE) — encompassing deep vein thrombosis (DVT) and pulmonary embolism (PE) — requires structured diagnostic reasoning, timely treatment and careful assessment of recurrence and bleeding risks.
The Internal Medness VTE Guidelines Series will translate key guideline recommendations into practical clinical learning.
Topics covered:
- Diagnosis: Clinical probability scores, D-dimer and appropriate imaging
- DVT management: Diagnostic pathways and anticoagulation
- Pulmonary embolism: Haemodynamic assessment and risk stratification
- Anticoagulant selection: DOACs, LMWH, unfractionated heparin and vitamin K antagonists
- Duration of treatment: Provoked versus unprovoked VTE and recurrence risk
- High-risk PE: Reperfusion strategies and escalation of care
- Special populations: Cancer-associated thrombosis, pregnancy and renal impairment
- Prevention: Hospital-associated VTE, recurrence prevention and selected indications for thrombophilia testing
Key clinical principle:
Anticoagulation decisions should account for clot location and severity, haemodynamic status, bleeding risk, comorbidities and patient preferences. Treatment duration should be individualised rather than determined by a one-size-fits-all rule.
The series will draw on established guidance, including NICE and American Society of Hematology recommendations, while highlighting practical decision-making points.
Follow Internal Medness for concise, clinically relevant internal medicine education.
Dr. Parth Parmar
M.B.B.S | M.D Internal Medicine
INTERNAL MEDNESS
Learn • Revise • Excel
Your 1-Minute Harrison.”
Stay updated with Hemostasis Today.
-
Oct 11, 2026, 15:31Muhammad Alvi: CASPR Study Explores Treatment Response Across ESUS Phenotypes
-
Oct 11, 2026, 15:15Thalassaemia International Federation Joins ASCAT 2026 to Advance Sickle Cell and Thalassaemia Care
-
Oct 11, 2026, 15:14Challenges and Perspectives on Gene Therapy in Hemophilia A – Seminars in Thrombosis and Hemostasis
-
Oct 11, 2026, 15:07Neysa Rahardjo: Platelet Estimation Pitfalls and Discrepancy Resolution
-
Oct 11, 2026, 15:05Lance Trewhella: Reflections from the ASCLS Region V Fall Symposium
-
Oct 11, 2026, 15:04The Anti-Inflammatory Rationale for GLP-1 Agonists in Hemophilia – CRH French Reference Center for Hemophilia Lyon
-
Oct 11, 2026, 15:00Donja W.: Blood Shortages Aren’t Just Statistics
-
Oct 11, 2026, 14:54Archil Jaliashvili: NHSBT Highlights Persistent Gaps in Matched Blood for Sickle Cell Patients
-
Oct 11, 2026, 14:46Sebastien Lobet: Physiotherapy and Joint Health Across the Spectrum of Bleeding Disorders